144 related articles for article (PubMed ID: 28238243)
1. Improved Pig Model to Evaluate Heart Valve Thrombosis.
Payanam Ramachandra U; Shenoy SJ; Arumugham S
J Heart Valve Dis; 2016 Sep; 25(5):606-612. PubMed ID: 28238243
[TBL] [Abstract][Full Text] [Related]
2. Initial experience with dual antiplatelet thromboprophylaxis using clopidogrel and aspirin in patients with mechanical aortic prostheses.
García-Rinaldi R; Carro-Pagán C; Schaff HV; McKellar SH; Thompson JL; Quiñones J; Rodríguez-Acosta JF
J Heart Valve Dis; 2009 Nov; 18(6):617-25; discussion 626. PubMed ID: 20099710
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
Owais T; Rouman M; Breuer M; Hüter L; Fuchs J; Lauer B; Kuntze T
J Heart Valve Dis; 2016 Mar; 25(2):139-144. PubMed ID: 27989055
[TBL] [Abstract][Full Text] [Related]
4. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
Vilahur G; Segalés E; Salas E; Badimon L
Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
[TBL] [Abstract][Full Text] [Related]
5. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
[TBL] [Abstract][Full Text] [Related]
6. Platelet reactivity in MitraClip patients.
Polzin A; Afzal S; Balzer J; Rassaf T; Kelm M; Zeus T
Vascul Pharmacol; 2016 Feb; 77():54-9. PubMed ID: 26239882
[TBL] [Abstract][Full Text] [Related]
7. Clopidogrel-aspirin inhibit the thrombogenicity of St. Jude mechanical aortic prostheses.
García-Rinaldi R
Ann Thorac Surg; 2006 Feb; 81(2):787; author reply 788. PubMed ID: 16427911
[No Abstract] [Full Text] [Related]
8. Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves.
McKellar SH; Abel S; Camp CL; Suri RM; Ereth MH; Schaff HV
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1410-6. PubMed ID: 21429525
[TBL] [Abstract][Full Text] [Related]
9. Effects of combined therapy of clopidogrel and aspirin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model.
Schlitt A; Hauroeder B; Buerke M; Peetz D; Victor A; Hundt F; Bickel C; Meyer J; Rupprecht HJ
Thromb Res; 2002 Jul; 107(1-2):39-43. PubMed ID: 12413587
[TBL] [Abstract][Full Text] [Related]
10. Cardiology patient page. Antiplatelet therapy.
Harrington RA; Hodgson PK; Larsen RL
Circulation; 2003 Aug; 108(7):e45-7. PubMed ID: 12925447
[No Abstract] [Full Text] [Related]
11. Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine.
McKellar SH; Thompson JL; Garcia-Rinaldi RF; Macdonald RJ; Sundt TM; Schaff HV
J Thorac Cardiovasc Surg; 2008 Oct; 136(4):908-14. PubMed ID: 18954629
[TBL] [Abstract][Full Text] [Related]
12. Bioactive surface coating for preventing mechanical heart valve thrombosis.
Lancellotti P; Aqil A; Musumeci L; Jacques N; Ditkowski B; Debuisson M; Thiry M; Dupont J; Gougnard A; Sandersen C; Cheramy-Bien JP; Sakalihasan N; Nchimi A; Detrembleur C; Jérôme C; Oury C
J Thromb Haemost; 2023 Sep; 21(9):2485-2498. PubMed ID: 37196847
[TBL] [Abstract][Full Text] [Related]
13. Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
Windecker S; Tijssen J; Giustino G; Guimarães AH; Mehran R; Valgimigli M; Vranckx P; Welsh RC; Baber U; van Es GA; Wildgoose P; Volkl AA; Zazula A; Thomitzek K; Hemmrich M; Dangas GD
Am Heart J; 2017 Feb; 184():81-87. PubMed ID: 27892890
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a swine model to assess the preclinical safety of mechanical heart valves.
Grehan JF; Hilbert SL; Ferrans VJ; Droel JS; Salerno CT; Bianco RW
J Heart Valve Dis; 2000 Sep; 9(5):710-9; discussion 719-20. PubMed ID: 11041189
[TBL] [Abstract][Full Text] [Related]
15. Platelet survival in patients with prosthetic heart valves.
Stuart RK; McDonald JW; Ahuja SP; Coles JC
Am J Cardiol; 1974 Jun; 33(7):840-4. PubMed ID: 4597816
[No Abstract] [Full Text] [Related]
16. Influence of low-intensity anticoagulation and low-dose antiplatelet agent on coagulation-fibrinolysis system after mechanical prosthetic valve replacement.
Moriyama Y; Nakamura K; Kariyazono H; Toyohira H; Taira A
J Thorac Cardiovasc Surg; 1998 Apr; 115(4):952-4. PubMed ID: 9576237
[No Abstract] [Full Text] [Related]
17. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
[TBL] [Abstract][Full Text] [Related]
18. [Significance of combined use of anticoagulants and antiplatelet agents in the early stage after prosthetic valve replacement].
Toyohira H; Nakamura K; Kariyazono H; Yamada K; Moriyama Y; Shimokawa S; Saigenji H; Taira A
Kyobu Geka; 1995 Aug; 48(9):749-55. PubMed ID: 7564036
[TBL] [Abstract][Full Text] [Related]
19. Impact of adjunctive cilostazol therapy versus high maintenance dose of clopidogrel in suboptimal responders with diabetes mellitus.
Ferreiro JL; Ueno M; Desai B; Capranzano P; Capodanno D; Angiolillo DJ
Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):105-6. PubMed ID: 21783310
[No Abstract] [Full Text] [Related]
20. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves.
Kasimir MT; Rieder E; Seebacher G; Nigisch A; Dekan B; Wolner E; Weigel G; Simon P
J Heart Valve Dis; 2006 Mar; 15(2):278-86; discussion 286. PubMed ID: 16607912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
